Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari: Documento intersocietario di consenso

Translated title of the contribution: The role of adherence to pharmacological treatment in the chronic therapy of cardiovascular diseases: Intercompany consensus document

Massimo Volpe, Luca Degli Esposti, Francesco Romeo, Bruno Trimarco, Francesco Maria Bovenzi, Vittoria Mastromarino, Allegra Battistoni

Research output: Contribution to journalArticle

Abstract

Chronic therapy with statins, antihypertensive and antiplatelet drugs is one of the most important interventions for primary and secondary prevention of cardiovascular disease. Adherence to drug treatment is key to successful therapeutic intervention, especially in chronic conditions. This holds particularly true in the setting of cardiovascular diseases, because poor adherence may have serious adverse effects in terms of morbidity and mortality. Many factors may contribute to poor adherence, which can be either patient-related or dependent on the healthcare system, the physician and the environment. The identification and appropriate correction of these factors may result in both clinical and economic benefits. In this setting it is also important to assess the implications of the increasing use of generic or equivalent drugs on adherence to pharmacological therapy.

Original languageItalian
Pages (from-to)430-437
Number of pages8
JournalGiornale Italiano di Cardiologia
Volume15
Issue number10
Publication statusPublished - Oct 1 2014

Fingerprint

Cardiovascular Diseases
Pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Platelet Aggregation Inhibitors
Primary Prevention
Therapeutics
Secondary Prevention
Pharmaceutical Preparations
Antihypertensive Agents
Economics
Morbidity
Delivery of Health Care
Physicians
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Volpe, M., Esposti, L. D., Romeo, F., Trimarco, B., Bovenzi, F. M., Mastromarino, V., & Battistoni, A. (2014). Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari: Documento intersocietario di consenso. Giornale Italiano di Cardiologia, 15(10), 430-437.

Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari : Documento intersocietario di consenso. / Volpe, Massimo; Esposti, Luca Degli; Romeo, Francesco; Trimarco, Bruno; Bovenzi, Francesco Maria; Mastromarino, Vittoria; Battistoni, Allegra.

In: Giornale Italiano di Cardiologia, Vol. 15, No. 10, 01.10.2014, p. 430-437.

Research output: Contribution to journalArticle

Volpe, M, Esposti, LD, Romeo, F, Trimarco, B, Bovenzi, FM, Mastromarino, V & Battistoni, A 2014, 'Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari: Documento intersocietario di consenso', Giornale Italiano di Cardiologia, vol. 15, no. 10, pp. 430-437.
Volpe, Massimo ; Esposti, Luca Degli ; Romeo, Francesco ; Trimarco, Bruno ; Bovenzi, Francesco Maria ; Mastromarino, Vittoria ; Battistoni, Allegra. / Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari : Documento intersocietario di consenso. In: Giornale Italiano di Cardiologia. 2014 ; Vol. 15, No. 10. pp. 430-437.
@article{2c0eb308e01b4f41bd8d032329299055,
title = "Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari: Documento intersocietario di consenso",
abstract = "Chronic therapy with statins, antihypertensive and antiplatelet drugs is one of the most important interventions for primary and secondary prevention of cardiovascular disease. Adherence to drug treatment is key to successful therapeutic intervention, especially in chronic conditions. This holds particularly true in the setting of cardiovascular diseases, because poor adherence may have serious adverse effects in terms of morbidity and mortality. Many factors may contribute to poor adherence, which can be either patient-related or dependent on the healthcare system, the physician and the environment. The identification and appropriate correction of these factors may result in both clinical and economic benefits. In this setting it is also important to assess the implications of the increasing use of generic or equivalent drugs on adherence to pharmacological therapy.",
author = "Massimo Volpe and Esposti, {Luca Degli} and Francesco Romeo and Bruno Trimarco and Bovenzi, {Francesco Maria} and Vittoria Mastromarino and Allegra Battistoni",
year = "2014",
month = "10",
day = "1",
language = "Italian",
volume = "15",
pages = "430--437",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "10",

}

TY - JOUR

T1 - Il ruolo dell'aderenza al trattamento farmacologico nella terapia cronica delle malattie cardiovascolari

T2 - Documento intersocietario di consenso

AU - Volpe, Massimo

AU - Esposti, Luca Degli

AU - Romeo, Francesco

AU - Trimarco, Bruno

AU - Bovenzi, Francesco Maria

AU - Mastromarino, Vittoria

AU - Battistoni, Allegra

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Chronic therapy with statins, antihypertensive and antiplatelet drugs is one of the most important interventions for primary and secondary prevention of cardiovascular disease. Adherence to drug treatment is key to successful therapeutic intervention, especially in chronic conditions. This holds particularly true in the setting of cardiovascular diseases, because poor adherence may have serious adverse effects in terms of morbidity and mortality. Many factors may contribute to poor adherence, which can be either patient-related or dependent on the healthcare system, the physician and the environment. The identification and appropriate correction of these factors may result in both clinical and economic benefits. In this setting it is also important to assess the implications of the increasing use of generic or equivalent drugs on adherence to pharmacological therapy.

AB - Chronic therapy with statins, antihypertensive and antiplatelet drugs is one of the most important interventions for primary and secondary prevention of cardiovascular disease. Adherence to drug treatment is key to successful therapeutic intervention, especially in chronic conditions. This holds particularly true in the setting of cardiovascular diseases, because poor adherence may have serious adverse effects in terms of morbidity and mortality. Many factors may contribute to poor adherence, which can be either patient-related or dependent on the healthcare system, the physician and the environment. The identification and appropriate correction of these factors may result in both clinical and economic benefits. In this setting it is also important to assess the implications of the increasing use of generic or equivalent drugs on adherence to pharmacological therapy.

UR - http://www.scopus.com/inward/record.url?scp=84916926409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916926409&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84916926409

VL - 15

SP - 430

EP - 437

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 10

ER -